Important update: UPMC Health Plan 835 readmits

May 2024Important Notices

UPMC Health Plan has discovered an issue with some of the Electronic Remittance Advice (835) data that was sent to providers. The issue—which is related to a systems enhancement—exists only within the 835 data. No issues have been found on Explanations of Payment or Explanations of Benefits.

The enhancement was implemented on April 25, 2024. As such, 835s created on or after April 26 may have been impacted.

Please note that we are working on a change that should resolve the issue within the next week, and we hope to provide a count of the providers and claims that were impacted. In the meantime, we have rolled back the 835 enhancements so that all 835s created on or after May 7 at 3 p.m. are correct.

If you have any questions about this matter, please contact your physician account executive or call Provider Services at 1-866-918-1595.

Recent Announcements

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates

Medicaid provider update: High-cost Medicaid drug billing

Billing requirements for Medicaid-covered drugs
Nov. 2025Important Notices

Training Webinar: Conversio Health COPD Management Program

Please join us for a live training webinar for primary care providers and pulmonologists by UPMC Health Plan that will provide an overview of a comprehensive COPD management program from Conversio Health.
Nov. 2025Education/Webinars